137 related articles for article (PubMed ID: 8081963)
1. Vasoactive substances as regulators of renal growth.
Wolf G
Exp Nephrol; 1993; 1(3):141-51. PubMed ID: 8081963
[TBL] [Abstract][Full Text] [Related]
2. Interactions of the vasoconstrictor peptides, angiotensin II and endothelin-1, with vasodilatory prostaglandins.
Schramek H; Coroneos E; Dunn MJ
Semin Nephrol; 1995 May; 15(3):195-204. PubMed ID: 7631046
[TBL] [Abstract][Full Text] [Related]
3. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
Wolf G
Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
[TBL] [Abstract][Full Text] [Related]
5. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
6. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
[TBL] [Abstract][Full Text] [Related]
7. Effects of peptide vasoconstrictors on vessel structure.
Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
Dubey RK
J Pharmacol Exp Ther; 1994 Apr; 269(1):402-8. PubMed ID: 8169847
[TBL] [Abstract][Full Text] [Related]
10. Alterations in renal function in experimental congestive heart failure.
Awazu M; Ichikawa I
Semin Nephrol; 1994 Sep; 14(5):401-11. PubMed ID: 7997647
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat.
Yamaguchi N; Jesmin S; Zaedi S; Shimojo N; Maeda S; Gando S; Koyama A; Miyauchi T
Peptides; 2006 Sep; 27(9):2258-70. PubMed ID: 16725227
[TBL] [Abstract][Full Text] [Related]
12. [Interaction between angiotensin II and other local vasoactive substances].
Kobayashi N; Matsuoka H
Nihon Rinsho; 1999 May; 57(5):1110-6. PubMed ID: 10361443
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide/endothelin balance after nephron reduction.
Aiello S; Remuzzi G; Noris M
Kidney Int Suppl; 1998 Apr; 65():S63-7. PubMed ID: 9551434
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats.
Moreno JM; Wangensteen R; Sainz J; Rodríguez-Gomez I; Chamorro V; Osuna A; Vargas F
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E182-8. PubMed ID: 12657567
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular hypertrophy induced by angiotensin II.
Wolf G; Ziyadeh FN
Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
[TBL] [Abstract][Full Text] [Related]
16. Endothelin in the progressive renal disease of glomerulopathies.
Benigni A; Remuzzi G
Miner Electrolyte Metab; 1995; 21(4-5):283-91. PubMed ID: 7565477
[TBL] [Abstract][Full Text] [Related]
17. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
Kim S; Iwao H
Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
[TBL] [Abstract][Full Text] [Related]
19. Regulation of renal tubular sodium transport by angiotensin II and atrial natriuretic factor.
Harris PJ; Hiranyachattada S; Antoine AM; Walker L; Reilly AM; Eitle E
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S112-8. PubMed ID: 8993849
[TBL] [Abstract][Full Text] [Related]
20. [The vasoactive systems in the regulation of renal hemodynamics].
Morimoto R; Ito S
Nihon Rinsho; 2005 Jan; 63(1):64-7. PubMed ID: 15675319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
